Diffusion tensor imaging of the hippocampus predicts the risk of dementia; the RUN DMC study

Human Brain Mapping

Volumn 37, Issue 1, 2016, Pages 327-337

  van Uden, I W M ^a   Tuladhar, A M ^a   van der Holst, H M ^a   van Leijsen, E M C ^a   van Norden, A G W ^b   de Laat, K F ^c   Rutten Jacobs, L C A ^d   Norris, D G ^a,e   Claassen, J A H R ^a   van Dijk, E J ^a   Kessels, R P C ^a   de Leeuw, F E ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cerebral small vessel disease; Dementia; Diffusion tensor imaging; Elderly; Hippocampus; Imaging; Magnetic resonance imaging

Indexed keywords

AGED; ARTICLE; BRAIN REGION; BRAIN SIZE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DEMENTIA; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; WHITE MATTER; ANISOTROPY; COMPLICATION; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANISOTROPY; CEREBRAL SMALL VESSEL DISEASES; DEMENTIA; DIFFUSION TENSOR IMAGING; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 84954375698     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.23029     Document Type: Article

References (47)

1. Alvarez P, Zola-Morgan S, Squire LR (1995): Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys. J Neurosci 15:3796-3807.
2. American Psychiatric Association (2000): Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC.
3. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, D'Agostino RB, DeCarli C (2006): Association of white matter hyperintensity volume with decreased cognitive functioning: The Framingham Heart Study. Arch Neurol 63:246-250.
4. Basser PJ, Mattiello J, LeBihan D (1994): Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson Ser B 103:247-254.
5. Braak H, Braak E (1997): Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 18:S85-S88.
6. Breteler MM (2000): Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 21:153-160.
7. Carlesimo GA, Cherubini A, Caltagirone C, Spalletta G (2010): Hippocampal mean diffusivity and memory in healthy elderly individuals: A cross-sectional study. Neurology 74:194-200.
8. Cherubini A, Peran P, Spoletini I, Di Paola M, Di Iulio F, Hagberg GE, Sancesario G, Gianni W, Bossu P, Caltagirone C, Sabatini U, Spalletta G (2010): Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J Alzheimer's Dis 19:1273-1282.
9. Clerx L, Visser PJ, Verhey F, Aalten P (2012): New MRI markers for Alzheimer's disease: A meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. J Alzheimer's Dis 29:405-429.
10. Colliot O, Chetelat G, Chupin M, Desgranges B, Magnin B, Benali H, Dubois B, Garnero L, Eustache F, Lehericy S (2008): Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 248:194-201.
11. de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MM (2000): Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 47:145-151.
12. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM (2001): Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70:9-14.
13. de Leeuw FE, Barkhof F, Scheltens P (2004): White matter lesions and hippocampal atrophy in Alzheimer's disease. Neurology 62:310-312.
14. de Leeuw FE, Korf E, Barkhof F, Scheltens P (2006): White matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease. Stroke 37:2248-2252.
15. den Heijer T, der Lijn F, Vernooij MW, de Groot M, Koudstaal PJ, der Lugt A, Krestin GP, Hofman A, Niessen WJ, Breteler MM (2012): Structural and diffusion MRI measures of the hippocampus and memory performance. Neuroimage 63:1782-1789.
16. Dziedzic T, Metz I, Dallenga T, Konig FB, Muller S, Stadelmann C, Bruck W (2010): Wallerian degeneration: A major component of early axonal pathology in multiple sclerosis. Brain Pathol 20:976-985.
17. Erkinjuntti T (2002): Subcortical vascular dementia. Cerebrovasc Dis 13 Suppl 2:58-60.
18. Fellgiebel A, Wille P, Muller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P (2004): Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: A diffusion tensor imaging study. Dement Geriatr Cogn Disord 18:101-108.
19. Fellgiebel A, Dellani PR, Greverus D, Scheurich A, Stoeter P, Muller MJ (2006): Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Res 146:283-287.
20. Folstein MF, Folstein SE, McHugh PR (1975): "Mini-mental state". A practical method for grading the cognitive state of Patients for the Clinician. J Psychiatric Res 12:189-198.
21. Fratiglioni L, De Ronchi D, Aguero-Torres H (1999): Worldwide prevalence and incidence of dementia. Drugs Aging, 15:365-375.
22. Geuze E, Vermetten E, Bremner JD (2005): MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 10:160-184.
23. Hochstenbach J, Mulder T, van Limbeek J, Donders R, Schoonderwaldt H (1998): Cognitive decline following stroke: A comprehensive study of cognitive decline following stroke. J Clin Exp Neuropsychol 20:503-517.
24. Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F, Scheltens P, Madureira S, Verdelho A, Ferro JM, Wallin A, Poggesi A, Inzitari D, Pantoni L, Erkinjuntti T, Group LS (2013): Diffusion changes predict cognitive and functional outcome: the LADIS study. Ann Neurol 73:576-583.
25. Jones DK, Lythgoe D, Horsfield MA, Simmons A, Williams SC, Markus HS (1999): Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke 30:393-397.
26. Launer LJ (2002): Demonstrating the case that AD is a vascular disease: Epidemiologic evidence. Ageing Res Rev 1:61-77.
27. Manjon JV, Coupe P, Concha L, Buades A, Collins DL, Robles M (2013): Diffusion weighted image denoising using overcomplete local PCA. PloS One 8:e73021
28. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011): The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement 7:263-269.
29. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A (1998): Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147:574-580.
30. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G (1996): Diffusion tensor MR imaging of the human brain. Radiology 201:637-648.
31. Richard E, Moll van Charante EP, van Gool WA (2012): Vascular risk factors as treatment target to prevent cognitive decline. J Alzheimer's Dis 32:733-740.
32. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DPhil, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993): Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250-260.
33. Seo SW, Ahn J, Yoon U, Im K, Lee JM, Tae Kim S, Ahn HJ, Chin J, Jeong Y, Na DL (2010): Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type. J Neuroimaging 20:37-45.
34. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20:22-33;quiz 34-57.
35. Squire LR, Stark CE, Clark RE (2004): The medial temporal lobe. Annu Rev Neurosci 27:279-306.
36. van Norden AG, de Laat KF, Gons RA, van Uden IW, van Dijk EJ, van Oudheusden LJ, Esselink RA, Bloem BR, van Engelen BG, Zwarts MJ, Tendolkar I, Olde-Rikkert MG, van der Vlugt MJ, Zwiers MP, Norris DG, de Leeuw FE (2011): Causes and consequences of cerebral small vessel disease. The RUN DMC study: A prospective cohort study. Study rationale and protocol. BMC Neurol 11:29
37. van Norden AG, de Laat KF, Fick I, van Uden IW, van Oudheusden LJ, Gons RA, Norris DG, Zwiers MP, Kessels RP, de Leeuw FE (2012a): Diffusion tensor imaging of the hippocampus and verbal memory performance: The RUN DMC study. Hum Brain Mapp 33:542-551.
38. van Norden AG, van Dijk EJ, de Laat KF, Scheltens P, Olderikkert MG, de Leeuw FE (2012b): Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction. Biochim Biophys Acta 1822:340-349.
39. van Uden IW, Tuladhar AM, de Laat KF, van Norden AG, Norris DG, van Dijk EJ, Tendolkar I, de Leeuw FE (2014): White Matter Integrity and Depressive Symptoms in Cerebral Small Vessel Disease: The RUN DMC Study. Am J Geriatr Psychiatry. 23:525-535. doi: 10.1016/j.jagp.2014.07.002.
40. Verdelho A, Madureira S, Moleiro C, Ferro JM, O'Brien JT, Poggesi A, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D, Study L (2013): Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 84:1250-1254.
41. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003): Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348:1215-1222.
42. Viswanathan A, Rocca WA, Tzourio C (2009): Vascular risk factors and dementia: How to move forward? Neurology 72:368-374.
43. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge R, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M nEuroimaging STfRV, co (2013): Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822-838.
44. Wiesmann M, Kiliaan AJ, Claassen JA (2013): Vascular aspects of cognitive impairment and dementia. J Cerebral Blood Flow Metabolism 33:1696-1706.
45. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006): User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 31:1116-1128.
46. Zola-Morgan S, Squire LR, Amaral DG (1986): Human amnesia and the medial temporal region: Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 6:2950-2967.
47. Zwiers MP (2010): Patching cardiac and head motion artefacts in diffusion-weighted images. Neuroimage 53:565-575.